Condition
Abemaciclib clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Abemaciclib clinical trials that are recruiting, at sites in 4 countries (most in China (1), Italy (1), Japan (1)). By phase: Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 4Countries
Newest Abemaciclib clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Adherence to Cell Cycle Inhibitors with Endocrine Therapy in Localized High-Risk ER+ Breast Cancer | — | Grenoble | Recruiting | Mar 2, 2026 |
| Gut microbiome differences in people on abemaciclib who do or don't get diarrhea | — | Wuhan, Hubei | Recruiting | Dec 4, 2025 |
| Adjuvant abemaciclib plus hormone therapy after locoregional recurrence of HR-positive, HER2-negative breast cancer | Phase 3 | Koto-ku, Tokyo | Recruiting | Sep 24, 2025 |
| Predicting outcomes for advanced breast cancer patients treated with CDK4/6 inhibitors and endocrine therapy | — | Aviano and 23 other locations | Recruiting | Feb 3, 2025 |
All recruiting trials (4)
-
Adherence to Cell Cycle Inhibitors with Endocrine Therapy in Localized High-Risk ER+ Breast Cancer
This study checks how well patients with localized ER+ breast cancer stick to a combined endocrine therapy and CDK4/6 inhibitor after surgery.
-
Gut microbiome differences in people on abemaciclib who do or don't get diarrhea
This project will compare gut bacteria in people with HR-positive breast cancer who are taking abemaciclib to see if differences are linked to developing diarrhea.
-
Adjuvant abemaciclib plus hormone therapy after locoregional recurrence of HR-positive, HER2-negative breast cancer
This will test whether adding abemaciclib to standard hormone therapy helps people with HR-positive, HER2-negative breast cancer who have had their first locoregional recurrence.
-
Predicting outcomes for advanced breast cancer patients treated with CDK4/6 inhibitors and endocrine therapy
This study is trying to see how well different CDK4/6 inhibitors combined with hormone therapy work for people with advanced breast cancer and how safe they are.
Related topics
Quick answers
How many Abemaciclib clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in China (1 trial), Italy (1 trial), Japan (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.